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A key step in organogenesis of the Drosophila tracheal system is the integration of isolated tracheal metameres into a connected tubular
network. The interaction of tracheal cells with surrounding mesodermal cells is crucial in this process. In particular, single mesodermal cells called
bridge-cells are essential for the guided outgrowth of dorsal trunk branches to direct formation of the main airway, the dorsal trunk. Here, we
present evidence that the two leucine-rich repeat transmembrane proteins Capricious and Tartan contribute differently to the formation of branch
interconnections during tracheal development. Capricious is specifically localized on the surface of bridge-cells and facilitates the outgrowing
dorsal trunk cells of adjacent metameres toward each other. We show that Capricious requires both extracellular and intracellular domains during
tracheal branch outgrowth. In contrast, Tartan is expressed broadly in mesodermal cells and exerts its role in tracheal branch outgrowth through its
extracellular domain. We propose that Capricious contributes to the instructive role of bridge-cells whereas Tartan provides permissive substrate
for the migrating tracheal cells during the network formation.
© 2006 Elsevier Inc. All rights reserved.Keywords: Drosophila; capricious; tartan; Bridge-cell; Tracheal developmentIntroduction
Cell motility and tissue movements are crucial in many
biological processes including organ development of multicel-
lular animals. The migrating cells recognize external cues and
substrates in order to move in an organized pattern along distinct
paths. Cell surface proteins are central in receiving and
transferring the external signals provided by long-range acting
chemoattractants and/or short-range cell-to-cell communication.
The Drosophila tracheal system is a particularly traceable in
vivo model for studying molecular and cellular mechanisms of⁎ Corresponding author.
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doi:10.1016/j.ydbio.2006.04.462directed cell movements. The development of the tracheal
system initiates with differentiation of ectodermal cells in ten
isolated clusters at each side of the embryo. Cell movements,
which are strictly coordinated along or across the surrounding
tissues, lead to stereotypical branch outgrowth from these
clusters. Finally, fusion of branches from adjacent cell clusters
results in interconnection of separated units into a three-
dimensional network of tubes (Manning and Krasnow, 1993;
Samakovlis et al., 1996a,b).
The initial outgrowth of tracheal cells from the clusters is
triggered by branchless (bnl), a gene encoding aDrosophilaFGF
homolog (dFGF/Bnl). Bnl is expressed dynamically in small
groups of cells surrounding the tracheal primordia and acts as a
chemoattractant that guides outgrowth of primary tracheal
branches (Sutherland et al., 1996; Metzger and Krasnow, 1999).
In addition to theBnl-signaling, a cellular guidancemechanism is
essential for normal outgrowth of dorsal trunk branches. This
guidance requires single mesodermal cells called bridge-cells,
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and serve as guidance posts for the outgrowing dorsal trunk
branches (Wolf and Schuh, 2000). Initially, filopodia-like
extensions from anterior and posterior dorsal trunk cells get in
touchwith the bridge-cells, slide along the bridge-cell surface and
contact the opposite extensions (Wolf et al., 2002). The dorsal
trunk fusion process then starts with deposition of the epidermal
adhesion protein DEcadherin (DEcad) at the contact point
between the two fusion cells (Tanaka-Matakatsu et al., 1996).
Localizedat theadherens junctions,DEcad interactswithαandβ-
catenin (armadillo) that subsequentlybind the actin cytoskeleton.
A cytoskeleton-associated plakin Short Stop (shot), which
interacts with both actin and microtubules, is required for
DEcad accumulation at the fusion site (Lee and Kolodziej,
2002). Finally, each of fusion cells forms an intracellular tube and
the two lumens fuse and become continuous.
The molecular mechanisms underlying the initial cell-to-cell
contacts between the extending dorsal trunk cells and the
guiding bridge-cells are not yet known. The transcription factor
Hunchback (Hb) was shown to play a key role in bridge-cell
differentiation, which in turn is necessary for dorsal trunk fusion
(Wolf and Schuh, 2000). In addition, a recent study showed that
the transcription factors Extradenticle (Exd) and Homothorax
(Hth) are also expressed in the bridge-cells (Merabet et al.,
2005). However, neither of these transcription factors nor Bnl
may be directly involved in the recognition of bridge-cells by
tracheal extensions. Thus, it has been speculated that this
process is mediated by extracellular matrix and adhesion
molecules that are expressed on the surfaces of tracheal and
bridge cells (Wolf et al., 2002).
Here, we show that a cell adhesion molecule Capricious
(Caps), which represents a transmembrane protein containing
the leucine-rich repeat (LRR) motifs (Shishido et al., 1998), is
specifically expressed in the bridge-cells and is involved in the
formation of dorsal trunk branches. Analysis of both loss- and
gain-of-function mutations indicates that Caps function is
important for the bridge-cells to guide efficiently the extending
dorsal trunk cells along their surface. In contrast to Caps, another
cell adhesion protein Trn, which is highly related to Caps and
also consists of LRR motifs (Milan et al., 2001), is expressed
broadly in the muscle founder cells. Loss- and gain-of-function
phenotypes of trn mutants suggest that Trn may provide a
permissive substrate for the migrating dorsal and lateral trunk
cells. Interestingly, protein domain swap experiments demon-
strate that the extracellular domains of both proteins are largely
functionally equivalent while their intracellular domains are
distinct during tracheal development. Whereas the intracellular
domain of Trn is dispensable for its function, the intracellular
domain of Caps is essential and contributes to the function of
bridge-cells during tracheal pathfinding.
Materials and methods
Screening of P-element strains
2460 lethal P-element Drosophila strains from the Szeged Stock Center
(Deak et al., 1997) were screened as described previously (Samakovlis et al.,
1996a) for expression in metamerically repeated cells. The P-insertion sites ofsuch strains were localized by plasmid rescue and sequenced to identify the
responsible genes (Hemphälä et al., 2003).
Fly stocks
The following mutant alleles and fly strains were used: capsl(3)02937 (Carrera
et al., 1998), capsl(3)05121 (Abrell and Jäckle, 2001), caps65.2, caps-lacZ,
(Shishido et al., 1998), trn28.4, trnΔ2.9caps65.2 double mutant (Milan et al., 2001)
and trn-lacZ (Chang et al., 1993). The tracheal cells were labeled by staining
cytoplasmic β-Gal in the lacZ enhancer trap line 1-eve-1 (Perrimon et al., 1991).
To drive GAL4 expression in mesodermal cells, we used twi-GAL4 (Greig and
Akam, 1993). For misexpression studiesUAS-caps (Shishido et al., 1998),UAS-
capsEd, UAS-capsId (Taniguchi et al., 2000), UAS-trn (Milan et al., 2001), UAS-
trnEd (Milan et al., 2002), or UAS-lacZ were used. All fly strains were bred at
25°C.
Transgene expression constructs
UAS-capsEdtrnId and UAS-trnEdcapsId were generated by introducing
capsEdtrnId and trnEdcapsId hybrid constructs into pUAST (Brand and
Perrimon, 1993). CapsEdTrnId consists of extracellular domain of Caps (aa
1–470) and intracellular domain of Trn (aa 469–737) while TrnEdCapsId
contains extracellular domain of Trn (aa 1–492) and intracellular domain (aa
487–532) of Caps. In order to generate UAS-capsΔRH, UAS-capsΔY and UAS-
capsΔPDZ strains, RH (aa 478–479), Y (aa 507) and VTEL (aa 537–540) in
Caps intracellular domain were replaced with glycine or stop codon through
site-directed mutagenesis (QuikChange® Site-Directed Mutagenesis Kit,
Stratagene) and inserted into pUAST vector. The transgene constructs were
verified by sequencing and used for germline transformation. Finally, in vivo
expression was confirmed by in situ hybridization and antibody staining of
transgene embryos. Upon ectopic expression, the transgene constructs reveal
membrane associated expressions of modified Caps or Trn protein that are
indistinguishable from wild-type Caps and Trn localization, respectively (see
Supplement Material Fig. 1). Ectopic expression of CapsΔPDZ could not be
confirmed with the given anti-Caps antibody. However, the correct expression
and localization of CapsΔPDZ cannot be ruled out because the anti-Caps
antibody was produced against a protein sequence (AAGGYPYIAGNSRMI-
PVTEL) that contains the PDZ sequence and thus may fail to detect Caps
lacking the PDZ sequence (Shishido et al., 1998). We speculate that Caps-
ΔPDZ is normally expressed since we observe an ectopic phenotype after
CapsΔPDZ expression (Fig. 6B). For further analysis, only homozygous viable
P-element insertion lines were used. Also, two independent P-element
insertion lines of each transgene construct were examined to exclude
phenotypes caused by the P-element integration sites.
Statistical analysis
For the analysis of tracheal phenotypes, at least three independent
antibody stainings were performed. The interruptions in dorsal and lateral
trunks were counted at least two independent times. The total number of
interruptions were divided by total number of possible connections (18 in
each embryo) and converted to the percentage of total connections. The
rescued interruption rates were calculated by dividing the interruption rates by
the interruption rate of trn28.4 mutant embryos. N1 and N2 describe two
separate countings of embryos or two independent P-element insertion lines
of a single transgene construct. The average of N1 and N2 and the respective
standard deviation (depicted by ± and error bar in the charts) are presented
throughout this study.
Immunostaining and in situ hybridization
Immunostainings and RNA in situ hybridizations with whole-mount
embryos were performed as previously described (Goldstein and Freyberg,
1994). Primary antibodies used were the following: monoclonal antibody 2A12
(DSHB, Iowa) to visualize tracheal lumen, anti-Caps (kindly provided by S.M.
Cohen; Milan et al., 2001), anti-Trn (kindly provided by A. Laughon; Chang et
al., 1993), anti-β-Galactosidase (Promega), anti-Hb (Wolf et al., 2002), anti-
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in-POD (Roche). Secondary antibodies used were the following: biotinylated
goat anti-mouse IgM (Jackson), biotinylated horse anti-mouse IgG, biotinylated
goat anti-rabbit IgG, AP coupled goat anti-rabbit IgG (Vector Laboratories), goat
anti-mouse IgG-Cy3, goat anti-rabbit IgG-Cy3, goat anti-mouse IgG-Cy2, goat
anti-rabbit IgG-Cy2, goat anti-guinea pig-Cy3 (Molecular Probes). The
antisense RNA probes were generated from cDNAs of caps (Shishido et al.,
1998), trn (EST GH10871), hb (EST LD34229) and btl (Glazer and Shilo,
1991). The ESTs were ordered from ResGen. Vectastain® ABC elite kit or ABC-
AP kit (Vector Laboratories) and/or Tyramide Signal Amplification (NEN) were
used to enhance signal detection.
DNA sequence alignments
The Anopheles gambiae gene agCP14407 was identified as a Caps
homologous gene by using the blastp program at NCBI (Altschul et al.,
1990). The alignment using the lalign program (Myers and Miller, 1989) was
used to align Caps and agCP14407. The REP search program (Andrade et al.,
2000) was used to search for repeats in agCP14407. In addition, the TMHMM
program (http://www.cbs.dtu.dk/services/TMHMM-2.0/) was used to detect
putative transmembrane domains.
Results
Capricious is specifically expressed in the bridge-cell
In order to identify genes that are distinctively expressed in
the bridge-cells, we screened 2460 lethal P-element containing
Drosophila strains from the Szeged Stock Center (Deak et al.,
1997) for reporter gene expression in the bridge-cells (see
Materials and methods). Embryos from one of the P-element
lines showed β-Galactosidase (β-Gal) expression in metamer-
ically repeated cells at the presumptive bridge-cell positions
(Fig. 1A). Sequencing of genomic DNA flanking the P-element
revealed a gene called capricious (caps), which encodes a
transmembrane protein with 14 leucine-rich repeat (LRR)
motifs in the extracellular domain (Shishido et al., 1998).
These LRR motifs are frequently found in cell adhesion
molecules and may mediate cell-to-cell interactions (Kobe and
Deisenhofer, 1994). Previous work showed that caps affects the
target specificity of muscle 12 motorneurons during innervation
in larva (Shishido et al., 1998) and it mediates layer-specific
photoreceptor targeting in the visual system (Shinza-Kameda et
al., 2006). Caps has been also shown to contribute to the affinity
boundary formation between the dorsal and the ventral
compartments during wing development (Milan et al., 2001).
It was speculated that Caps exerts these functions by interacting
with cell surface molecules of neighboring cells (Shishido et al.,
1998; Milan et al., 2001).
In situ hybridization with caps antisense probe revealed that
endogenous caps is expressed in single cells in each metamere
as it was observed in caps-lacZ embryos (data not shown; see
Fig. 1A). Further analysis of caps expression in embryos
harboring a specific tracheal marker (1-eve-1; see Materials and
methods) revealed caps expression specifically in single cells
that are positioned at the posterior lateral side of each tracheal
metamere (Fig. 1B). This distinct expression disappears during
stage 13 when dorsal trunk cells fuse with each other (data not
shown). Earlier work demonstrated that nuclear lacZ expression
in caps-lacZ enhancer trap line E2-3-27 coincides with theexpression pattern of endogenous caps (Shishido et al., 1998).
Thus, caps-lacZ (E2-3-27) embryos were double stained with
anti-Hb antibody to label the bridge-cells and with anti-β-Gal
antibody to determine caps expression to verify that the
metamerically repeated cells expressing caps are indeed the
bridge-cells (Figs. 1C–E). During stage 11, Hb is expressed not
only in the bridge-cells but also in the more ventrally positioned
anchor-cells (Fig. 1C; Wolf and Schuh, 2000). Colocalization of
Hb and β-Gal is found in the bridge-cells but not in the anchor-
cells, demonstrating that Caps is expressed selectively in the
bridge-cells (Figs. 1D, E).
Caps contributes to the formation of dorsal trunk
Lack of bridge-cell function disrupts formation of a
continuous dorsal trunk (Wolf and Schuh, 2000). In order to
determine whether caps is required for the bridge-cell function,
the tracheal system development of various caps mutant alleles
(capsl(3)02937, capsl(3)05121 and caps65.2) was investigated.
Embryos of these caps alleles reveal a discontinuous dorsal
trunk formation (compare Figs. 1F with G). We noticed that the
frequency of interruptions vary among the embryos. To analyze
the tracheal phenotype more accurately, we counted interrup-
tions in the dorsal and the lateral trunk and represented them as
percentage of all possible fusions. All three caps mutant alleles
revealed similar rate of dorsal and lateral trunk interruptions and
the interruption rate in caps65.2 embryos is shown representa-
tively (Fig. 1H). We observed only 0.2% and 0.4% interruptions
in the dorsal trunks of wild-type embryos at stage 14 and during
later stages, respectively, while we detected 20.4% and 12.4%
dorsal trunk interruptions in caps65.2 mutants at the
corresponding stages. The significant variation in the severity
of dorsal trunk phenotypes implies that the extension of dorsal
trunk cells towards the corresponding targets may be stalled
rather than be completely inhibited when Caps is lacking. In
contrast, lateral trunk breaks were not significantly increased in
caps mutants (5.8%) compared to wild-type embryos (4.1%)
during stage 14 to 16.
Previous study revealed that Hb expression is essential for
the viability of bridge-cells (Wolf and Schuh, 2000). In mutant
embryos lacking hb, the bridge-cells undergo apoptosis and the
dorsal trunk cells cannot be guided efficiently. Consequently,
discontinuous dorsal trunks are formed. As caps mutant
embryos revealed similarly disrupted dorsal trunks, we asked
whether this phenotype is also result of apoptotic bridge-cells.
Hb is expressed in the bridge-cells of capsmutant embryos from
stage 10 to 13 as found in wild-type embryos indicating that the
viability of bridge-cells is not affected in caps mutants (Fig. 1I).
Furthermore, it was recently shown that bnl is specifically
expressed in the bridge-cells (Merabet et al., 2005). Thus, we
analyzed bnl expression in caps mutant embryos and found that
bnl is normally expressed in the bridge-cells of those embryos
(Figs. 1J–L). In summary, the interruptions in the dorsal trunk
despite the viable bridge-cells and the normal bnl expression in
capsmutant embryos suggest that caps function is important for
the bridge-cells to properly guide the dorsal trunk cells during
tracheal morphogenesis.
Fig. 1. Selective expression of caps in the bridge-cell is important for dorsal trunk formation. (A) caps-lacZ embryos were stained with anti-β-Gal antibody. A stage 10
embryo shows specific expression of β-Gal in metamerically repeated cells (arrows) on the lateral side of the embryo. (B) 1-eve-1 enhancer trap embryos were stained
with anti-β-Gal antibody (red) to visualize the tracheal cells. The embryos were also hybridized in situ with caps antisense RNA (blue). A stage 10 embryo reveals that
caps expressing cells are directly adjacent to the posterior lateral side of each tracheal metamere (arrows). (C–E) caps-lacZ embryos were stained with anti-β-Gal
(green) and anti-Hb (red) antibodies. The white dotted lines indicate the presumptive positions of the tracheal metameres during stage 12. C. A stage 12 embryo shows
Hb expression (red) in the bridge-cells (arrows) and the more ventral anchor-cells (arrowheads). (D) The same embryo shows β-Gal expression (green), which reveals
Caps expression in the bridge-cells (arrows) but not in the anchor-cells (arrowheads). (E) The overlay of green and red channels reveals colocalization of β-Gal (Caps)
and Hb selectively in the bridge-cells (arrows). (F, G) Wild-type (F) or caps65.2 embryos (G) were stained with the 2A12 antibody to visualize tracheal lumen. (F) A
wild-type embryo at stage 14 shows a continuous dorsal trunk. (G) In contrast, a caps65.2 embryo at stage 14 reveals gaps in the dorsal trunk at several positions
(arrows). Other tracheal branches appear to be as in wild-type embryos. (H) Interruptions of fusion points in caps65.2 and wild-type embryos were counted for the dorsal
trunks at early and late stages and for the lateral trunks. Early stage is defined as stage 14. Late stage is defined as later than stage 14. For all figures, the following
abbreviations are used: DT early, dorsal trunk in early stage embryos; DT late, dorsal trunk in late stage embryos; LT, lateral trunk; N, total number of fusion points
counted. Homozygous caps65.2 mutant embryos: DT early = 20.4% ± 0.8% (N1 = 918, N2 = 702), DT late = 12.4% ± 2.2% (N1 = 1008, N2 = 990), LT = 5.8% ± 0.4%
(N1 = 378, N2 = 396). Wild-type (OreR) embryos: DT early = 0.2% ± 0% (N1 = 558, N2 = 540), DT late = 0.4% ± 0.1% (N1 = 594, N2 = 576), LT = 4.1% ± 0.1%
(N1 = 594, N2 = 612). Note: Homozygous mutant embryos of capsl(3)02937 and capsl(3)05121 reveal tracheal interruptions as found for caps65.2. (I) caps65.2 mutant
embryos were stained with anti-Hb antibody to label the bridge-cells. A stage 12 caps65.2 embryo reveals Hb expression in the bridge-cells (arrows) as well as in the
anchor-cells (arrowheads), similarly as in the wild-type embryos. (J–L) caps65.2 embryos were hybridized in situ with bnl antisense RNA (red), hb antisense RNA
(green) and lacZ antisense RNA (not shown) to identify the homozygous caps mutant embryos. (J) A homozygous caps65.2 mutant embryo at stage 12 reveals bnl
expression in the bridge-cells (arrows). (K) Normal hb expression is detected in the bridge-cells (arrows) as well as in the anchor-cells (arrowheads). (L) The overlay
reveals coexpression of bnl and hb in the bridge-cells (arrows).
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Fig. 2. Misexpression of caps in mesodermal cells results in disrupted dorsal trunk and lateral trunk formation. (A, B) Embryos carryingUAS-caps and twi-GAL4were
stained with the 2A12 antibody to visualize the tracheal lumen. (A) Awhole-mount embryo at stage 14 reveals dorsal trunk interruptions at several fusion points. Some
of the truncated dorsal trunk branches appear in abnormal directions (arrows) instead of fusing with their adjacent targets. (B) Awhole-mount embryo at stage 15 also
shows a discontinuous lateral trunk (arrows indicate lateral trunk interruptions). (C) Interruptions of fusion points were counted for the dorsal trunks at early and late
stages and for the lateral trunks. Embryos bearing twi-GAL4 and UAS-caps: DT early = 23.5% ± 1.3% (N1 = 594, N2 = 576), DT late = 11.2% ± 0.4% (N1 = 576,
N2 = 612), LT = 28.4% ± 0.6% (N1 = 594, N2 = 504). Embryos bearing twi-GAL4 and UAS-capsEd: DT early = 3.7% ± 0.6% (N1 = 486, N2 = 414), DT
late = 1.4% ± 0.5% (N1 = 468, N2 = 486), LT = 15.2% ± 0.3% (N1 = 396, N2 = 522). Embryos bearing twi-GAL4 andUAS-capsId: DTearly = 3.2% ± 0.2% (N1 = 504,
N2 = 450), DT late = 0.7% ± 0.2% (N1 = 504, N2 = 450), LT = 5.8% ± 0.3% (N1 = 468, N2 = 468). Embryos bearing twi-GAL4 and UAS-lacZ: DT
early = 3.8% ± 0.2% (N1 = 576, N2 = 414), DT late = 0.8% ± 0.2% (N1 = 414, N2 = 486), LT = 6.4% ± 0.8% (N1 = 486, N2 = 432).
257C. Krause et al. / Developmental Biology 296 (2006) 253–264Next, we used the UAS-GAL4 system (Brand and Perrimon,
1993) to investigate whether ectopic caps expression in
mesodermal cells would interfere with the normal dorsal trunk
branch outgrowth. Similarly as in caps mutant embryos, the
dorsal trunk is interrupted at several positions in embryos
expressing ectopic caps through twi-GAL4 (Fig. 2A; compare
with Fig. 1G). Occasionally, we observe some dorsal trunk
branches in abnormal directions rather than in the normal
anterior–posterior direction (arrows in Fig. 2A). Interestingly,
ectopic Caps expression affects the outgrowth of not only the
dorsal trunk cells but also the lateral trunk cells. When Caps is
overexpressed in mesodermal cells surrounding the lateral
trunk, a discontinuous lateral trunk is formed (Fig. 2B).
Significantly lower interruption rates in the embryos carrying
twi-Gal4 and UAS-lacZ demonstrate that the phenotype of
ectopic caps expression is not an intrinsic effect of the UAS-
GAL4 system (Fig. 2C). Once again, we observe fewer breaks in
the dorsal trunk at late stages than at early stages (11.2%
compared to 23.5%). Previous studies of Caps in boundary
formation during wing disc morphogenesis revealed that Caps
requires only its extracellular domain (Ed) for its function
(Milan et al., 2002). Thus, we asked whether the intracellular
domain (Id) and/or the Ed of Caps is sufficient to mediate Caps
function during tracheal development as well. We therefore
expressed two deletion constructs lacking either the Id or the Ed
of Caps in mesodermal cells and analyzed their effects on the
tracheal development. When either the Id or the Ed of Caps is
lacking, normal development of the tracheal system wasobserved. For example, while the misexpression of complete
Caps in the mesodermal cells resulted in 23.5% interruptions in
the dorsal trunk of early stage embryos, only 3.7% or 3.2%
interruptions were observed in the embryos misexpressing
either the Ed or the Id of Caps, respectively (Fig. 2C). These
observations indicate that ectopic Caps interferes with normal
migration of tracheal cells so that the dorsal and the lateral trunk
branches fail to interconnect properly. Furthermore, both Id and
Ed are required for ectopic Caps function during tracheal
morphogenesis.
Mesodermal Tartan expression is essential for normal
formation of dorsal and lateral trunk
Caps shares high sequence homology with another cell
adhesion molecule named Tartan (Trn). It was demonstrated that
both proteins share redundant function in the formation of
affinity boundary between dorsal and ventral compartments
during wing imaginal disc development (Milan et al., 2001). To
test a possible role of trn during tracheal formation, we analyzed
branch interconnections in trn mutant embryos. Similar to caps,
trn mutants reveal discontinuous dorsal trunks (Fig. 3A).
Furthermore, trn and caps mutants show a comparable rate of
interruptions in the dorsal trunk in early as well as late stages.
For example, caps mutants contain 20.4% interruptions in the
dorsal trunks at early stages, while trn mutants reveal 20.5%
interruptions (Fig. 3B). However, whereas caps mutants form
normal lateral trunks, trn embryos reveal 21.7% disconnections
Fig. 3. Mesodermal tartan expression contributes to normal formation of the tracheal system. (A) A stage 14 trn28.4 mutant embryo stained with the 2A12 antibody
reveals gaps in the dorsal trunk (arrows) and the lateral trunk (arrowhead). (B) Interruptions of tracheal fusion points were counted in caps65.2, trn28.4, trnΔ2.9caps65.2
double mutant and wild-type embryos. Homozygous caps65.2mutant embryos: see Fig. 1H. Homozygous trn28.4mutant embryos: DTearly = 20.5% ± 0.3% (N1 = 774,
N2 = 810), DT late = 10.5% ± 0.5% (N1 = 720, N2 = 1476), LT = 21.7% ± 0.9% (N1 = 612, N2 = 684). trnΔ2.9caps65.2 double mutant embryos: DT
early = 39.2% ± 2.3% (N1 = 540, N2 = 522), DT late = 32.7% ± 0.9% (N1 = 342, N2 = 306), LT = 32.5% ± 1.5% (N1 = 360, N2 = 378). Wild-type embryos: see Fig.
1H. C. 1-eve-1 embryos were hybridized in situ with trn antisense RNA (green) to label trn expression and then stained with anti-β-Gal antibody (red) to mark the
tracheal cells. Awhole-mount embryo at stage 12 shows that trn is expressed in mesodermal cells adjacent to the tracheal metameres. Some lateral trunk cells appear to
be in direct contact with trn expressing cells (arrows). (D–F) trn-lacZ embryos were stained fluorescently with anti-β-Gal (green) and anti-Hb (red) antibodies. The
white dotted lines indicate the presumptive positions of tracheal metameres during stage 12. (D) Awhole-mount embryo at stage 12 shows Hb expression in the bridge-
cells (arrows). (E) The same embryo reveals β-Gal expression in a large number of mesodermal cells (muscle founder cells). (F) No colocalization of β-Gal and Hb is
detectable in the bridge-cells (arrow) and other mesodermal cells, indicating lack of Hb and Trn coexpression in mesodermal cells. (G) Interruptions of tracheal fusion
points in embryos misexpressing trn, trnEd or lacZ were counted. Embryos bearing twi-GAL4 and UAS-trn: DT early = 3.6% ± 0.4% (N1 = 522, N2 = 450), DT
late = 0.7% ± 0% (N1 = 450, N2 = 468), LT = 5.3% ± 0.6% (N1 = 450, N2 = 468). Embryos carrying twi-GAL4 and UAS-trnEd: DT early = 2.5% ± 0.2% (N1 = 378,
N2 = 468), DT late = 1.0% ± 0.1% (N1 = 450, N2 = 468), LT = 9.9% ± 0.2% (N1 = 378, N2 = 396). Embryos bearing twi-GAL4 and UAS-lacZ: see Fig. 2C.
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show discontinuous dorsal trunks, we asked whether the
functions of caps and trn are synergistic or additive. The
interruption rates in dorsal and lateral trunks of trnΔ2.9caps65.2
double mutant embryos are close to the sum of interruption rates
in trn or caps single mutant embryos (Fig. 3B) and suggest that
caps and trn function additively. Since both caps and trn
mutants demonstrate interrupted dorsal trunks, we asked
whether trn is also expressed in the bridge-cells. In contrast to
caps, trn is expressed in metamerically repeated clusters of
founder cells located laterally between the tracheal metameres
during early tracheal development (Artero et al., 2003, Fig. 3C).
The immediate juxtaposition between the tracheal extensionsand the muscle founder cells expressing trn suggests a direct
contact between these cells (Fig. 3C). In order to determine
whether the bridge-cells are included in these clusters of cells,
trn-lacZ embryos, which reveal β-Gal expression in trn patterns
(data not shown; Chang et al., 1993), were double labeled with
anti-Hb and anti-β-Gal antibodies. Interestingly, our results
indicate that trn is not expressed in the bridge-cells, suggesting
that trn contributes to dorsal trunk formation through a different
mechanism than caps (Figs. 3D–F). Overexpression of trn in
mesodermal cells further demonstrates that trn functions
distinctively from caps. Whereas embryos ectopically expres-
sing caps reveal more than 20% interruptions in dorsal and
lateral trunks (Fig. 2C), embryos overexpressing trn or Trn
Fig. 4. The extracellular domains of Caps and Trn reveal similar function during
tracheal morphogenesis. Interruptions of tracheal branch fusion in trn28.4
embryos carrying various caps and trn constructs were counted and compared to
the interruptions in trn28.4 mutant embryos (20.5%) and presented in percentage
of rescued interruptions. trn28.4 embryos bearing twi-GAL4 and UAS-trn: DT
early = 92.4% ± 8.4% (N1 = 756, N2 = 1152), DT late = 77.6% ± 0.9%
(N1 = 702, N2 = 954). trn28.4 embryos bearing twi-GAL4 and UAS-trnEd: DT
early = 78.1% ± 2.6% (N1 = 432, N2 = 414), DT late = 86.6% ± 5.2% (N1 = 396,
N2 = 504). trn28.4 embryos bearing twi-GAL4 and UAS-capsEd: DT
early = 47.5% ± 2.6% (N1 = 558, N2 = 666), DT late = 59.9% ± 1.9%
(N1 = 936, N2 = 576). trn28.4 embryos bearing twi-GAL4 and UAS-capsId: DT
early = −20.4% ± 0.7% (N1 = 522, N2 = 558), DT late = −12.7% ± 1.5%
(N1 = 522, N2 = 504). trn28.4 embryos bearing twi-GAL4 and UAS-caps: DT
early = −22.4% ± 0.9% (N1 = 576, N2 = 558), DT late = −31.1% ± 4.7%
(N1 = 576, N2 = 576).
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are comparable to that found in control embryos overexpressing
lacZ (Fig. 3G).
Thus, although function of caps and trn overlaps during
wing development, their roles differ during tracheal develop-
ment. First, we observe a similar dorsal trunk phenotype in
caps and trn mutants, but we detect lateral trunk breaks only
in trn mutant embryos. Second, caps and trn are expressed in
different patterns: caps is visible distinctively in the bridge-
cells whereas trn is detectable in founder cells but not in the
bridge-cells. Finally, ectopic expression of caps in mesoder-
mal cells interferes with dorsal trunk formation. In contrast,
trn overexpression does not affect tracheal development.
These results suggest that restricted expression of Caps
contributes to the bridge-cell function while the broad
mesodermal expression of Trn supports the outgrowth of
tracheal branches.
The extracellular domains of Caps and Trn provide similar
function during tracheal morphogenesis
Since mesodermal overexpression of trn did not influence
normal function of trn, we investigated whether it can
compensate for the tracheal defects in trn mutants. As
expected, the interruption rates in dorsal trunk could be
effectively rescued (Fig. 4). If Trn acts as a cell adhesion
molecule whose major function is to make a direct contact
with other cell adhesion molecules on the surface of dorsal
trunk cells, then its Ed might be sufficient for the normal role
during tracheal morphogenesis. Our observation that the
ectopic mesodermal Trn expression rescues the trn tracheal
phenotype prompted us to analyze whether the Ed including
the transmembrane region of Trn would be sufficient to
rescue trn tracheal dorsal trunk defects. Indeed, overexpres-
sion of TrnEd in mesodermal cells efficiently rescues the
dorsal trunk breaks of trn mutants (Fig. 4). This result implies
that Trn Ed is sufficient for the proper function of Trn during
dorsal trunk development.
Alignment of Caps and Trn amino acid sequences revealed
that most amino acid residues comprising the extracellular
domains and the transmembrane domains in Caps and Trn are
either similar or identical. However, the intracellular domains
are distinct and lack any considerable similarity. Since the Trn
Ed could rescue the tracheal phenotype in trn mutants and is
similar to Caps Ed, we asked whether Caps Ed would also be
able to rescue the tracheal defect in trn mutants. Thus, we
examined Caps, CapsId and CapsEd for their abilities to rescue
trn tracheal phenotype by overexpressing the corresponding
constructs in trn mutant embryos. We found that 47.5% of the
trn dorsal trunk defects could be rescued by expressing the
CapsEd construct, compared to 92.4% rescue by complete trn
(Fig. 4). This result implies that Caps extracellular domain is
competent to substitute partially for Trn function during dorsal
trunk formation. In contrast, when Caps or CapsId was
overexpressed in trn mutant embryos, the defects in dorsal
trunk formation could not be rescued but instead, became even
more severe (Fig. 4). These results infer that the extracellulardomain of either Caps or Trn can mediate trn function during
dorsal trunk development.
The intracellular domain specifies caps function
Loss- and gain-of-function experiments clearly demon-
strate that Caps and Trn play different roles during tracheal
development and it seems unlikely that the extracellular
domains of both proteins provide such differences. In order to
gain more insight into what dictates the functional specificity
of Caps and Trn, two different hybrid proteins consisting of
either the Ed (aa 1–470) of Caps and the Id (aa 469–737) of
Trn (CapsEdTrnId) or the Ed (aa 1–492) of Trn and the Id (aa
487–532) of Caps (TrnEdCapsId) were constructed (Fig. 5A).
We investigated whether these hybrid proteins could rescue
the tracheal defects of trn mutants. Overexpression of Caps-
EdTrnId in trn mutant embryos rescued the tracheal defects. In
contrast, TrnEdCapsId failed to rescue the dorsal trunk
interruptions and instead enhanced the tracheal phenotype of
trn mutants, i.e., such embryos revealed 11.2% more dorsal
trunk interruptions than trn mutants (Fig. 5B). Even though
the TrnEdCapsId hybrid protein contains the complete
extracellular domain of Trn, it not only fails to rescue trn
deficiencies in tracheal development, but rather aggravates the
dorsal trunk fusion defect. These data demonstrate that the
TrnEdCapsId hybrid protein functions similar to Caps,
indicating that the Id of Caps most likely mediates its
functional specificity.
Fig. 5. The intracellular domain of Caps mediates functional specificity. (A)
Generation of hybrid proteins is schematically shown. The Id of Trn is fused to
the Ed of Caps to generate CapsEdTrnId hybrid protein. Similarly, TrnEdCapsId
hybrid protein is generated by attaching the Id of Caps to the Ed of Trn. Ed,
extracellular domain; Id, intracellular domain. (B) Interruptions of tracheal
branch fusion in trn28.4 embryos carrying trn, caps and the hybrid constructs
were counted and presented in percentage of rescued interruptions. trn28.4
embryos bearing twi-GAL4 andUAS-trn: see Fig. 4. trn28.4 embryos bearing twi-
GAL4 and UAS-capsEdtrnId: DT early = 67.9% ± 1.2% (N1 = 252, N2 = 594),
DT late = 74.5% ± 6% (N1 = 450, N2 = 450), LT = 44.3% ± 1.1% (N1 = 342,
N2 = 612). trn28.4 embryos bearing twi-GAL4 and UAS-trnEdcapsId: DT
early = −11.2% ± 2.5% (N1 = 594, N2 = 450), DT late = −19.2% ± 1.8%
(N1 = 486, N2 = 468), LT = −8.6% ± 2.4%(N1 = 138, N2 = 117). For trn28.4
embryos carrying twi-GAL4 and UAS-caps: DT early and DT late (see Fig. 4).
LT = −17.6% ± 1.6% (N1 = 504, N2 = 486).
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Although Caps and Trn are both cell adhesion molecules
with largely functionally equivalent extracellular domains
during tracheal formation, they operate through divergent
mechanisms. Our results demonstrate that Trn does not
require its intracellular domain for its role during outgrowth
of dorsal trunk cells whereas Caps needs its intracellular
domain for proper function. To analyze the intracellular
domain of Caps in more detail and to identify conserved
protein domains, we searched for homologous protein
sequences (see Materials and methods). We identified a
putative Anopheles gambiae protein agCP14407, which
shows 40% sequence identity to Caps. Structure and sequence
analysis predicts that agCP14407 contains 14 LRR motifs, a
putative transmembrane domain and a signal peptide at the
amino-terminus as found for Caps. The high similarity in
sequence and structure suggests that agCP14407 (AgaCaps) is
the Anopheles homolog of the Drosophila Caps. Within the
intracellular domains of Caps and AgaCaps, three domains arepredominantly conserved (Fig. 6A): an RHR motif immedi-
ately after the transmembrane domain, a putative tyrosine
phosphorylation site and finally a putative PDZ-binding
motif. Interestingly, even though the last four amino acids
in AgaCaps and Caps are not identical, both match one of the
consensus C-terminal peptide sequences recognized by PDZ-
proteins: X-S/T-X-L, where X is an unspecified amino acid
(Sheng and Sala, 2001).
In order to analyze potential functions of the conserved
motifs, point mutations leading to amino acid substitutions were
introduced into caps cDNA sequence through site-directed
mutagenesis (see Materials and methods). RH in RHRmotif and
Y were substituted with glycine whereas a stop codon was
introduced before VTEL (Fig. 6A). The function of these altered
proteins was analyzed in vivo by ectopic mesodermal
expression in embryos. Misexpression of either UAS-capsΔY
or UAS-capsΔPDZ using the twi-GAL4 driver reveals tracheal
defects (Fig. 6B), and suggest Caps-like functions of these
mutagenized proteins. In contrast, both ectopic expressions of
CapsΔRH or β-Gal as control barely show any defects in
tracheal development (Fig. 6B). These results suggest that the
RHR motif is essential for Caps activity during the formation of
tracheal network.
Discussion
Caps expression in the bridge-cells contributes to the normal
dorsal trunk development
Single mesodermal cells called bridge-cells are required to
provide local guidance for the outgrowing dorsal trunk branches
(Wolf and Schuh, 2000). Here, we present evidence that Caps
contributes to the bridge-cell's function. Caps is specifically
expressed in the bridge-cells. When caps is lacking, the bridge-
cells may not bind the dorsal trunk cells effectively and thus fail
to provide sufficient guidance. Consequently, discontinuous
dorsal trunks are formed. As only dorsal trunk cells require
bridge-cell's guidance, other tracheal branches are not affected
by lack of caps activity.
What is the function of Caps in the bridge-cells? Caps
might be involved in directly mediating communication
between the bridge-cells and the tracheal cells, as it represents
a transmembrane protein with 14 leucine-rich repeats (LRR)
in the extracellular domain (Shishido et al., 1998). The crystal
structure of a ribonuclease inhibitor containing 15 LRRs
revealed that the LRRs are arranged consecutively and
parallel to a common axis so that the conformation resembles
a horseshoe (Kobe and Deisenhofer, 1995a), which is ideal
for mediating cell-to-cell interactions (Kobe and Deisenhofer,
1995b). Possibly, the extracellular domain of Caps assumes
the horseshoe-like conformation as well and binds molecules
localized on the surface of dorsal trunk cells. Thus, Caps may
provide an important link between the guiding bridge-cells
and the outgrowing tracheal cells.
When caps is ectopically expressed in mesodermal cells,
discontinuous dorsal as well as lateral trunks are formed.
Moreover, some dorsal trunk cells grow dorsally or ventrally
Fig. 6. The RHR motif in the intracellular domain is essential for Caps function.
(A) Sequence alignment of the intracellular domains of Drosophila Caps and
Anopheles Caps (AgCaps) using the lalign program (Myers and Miller, 1989).
Single letter code was used for the amino acid residues. Red letters and (:)
represent identical residues between Caps and AgCaps; (.) describes conserved
residues. The boxed residues represent three different conserved motifs: RHR
motif (violet), putative tyrosine phosphorylation site (blue) and putative PDZ
binding motif (turquoise). (B) Interruptions of tracheal branch fusion in embryos
that misexpress caps or mutagenized caps constructs. Embryos bearing twi-GAL4
and UAS-caps: see Fig. 2C. Embryos bearing twi-GAL4 and UAS-capsΔRH:
DT early = 5.8% ± 0.3% (N1 = 486, N2 = 450), DT late = 0.9% ± 0.1%
(N1 = 504, N2 = 432), LT = 4.9% ± 0.3% (N1 = 450, N2 = 486). Embryos
bearing twi-GAL4 and UAS-capsΔY: DT early = 15.2% ± 1.0% (N1 = 900,
N2 = 540), DT late = 8.0% ± 0.9% (N1 = 900, N2 = 486), LT = 10.3% ± 1.3%
(N1 = 900, N2 = 450). Embryos bearing twi-GAL4 and UAS-capsΔPDZ: DT
early = 14.7% ± 1.8% (N1 = 486, N2 = 432); DT late = 5.5% ± 1.2% (N1 = 432,
N2 = 504), LT = 13.1% ± 0.7% (N1 = 414, N2 = 468). Embryos bearing twi-
GAL4 and UAS-lacZ: see Fig. 2C.
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outgrowing tracheal cells may adhere to ectopic Caps on the
surface of mesodermal cells, which normally do not express
Caps, rather than binding endogenous Caps on the bridge-
cells. As a result, these tracheal cells may become disoriented
and extend in abnormal directions. This ability of ectopic
Caps to stall normal development of dorsal trunk branches
suggests that selective expression of Caps in the bridge-cells
is important for the specific local guidance for the outgrowing
dorsal trunk cells. However, more severe dorsal trunk defects
were observed in hb mutant embryos, which lack the bridge-
cells (Wolf and Schuh, 2000). This observation suggests that
additional components besides Caps are involved in the
bridge-cell's guidance. Such components may include the
chemoattractant Bnl, which is also expressed in the bridge-
cells (Merabet et al., 2005).Caps may function as a cell adhesion molecule and a receptor
Previous results demonstrated that Caps plays an essential
role during pathfinding of motorneurons, layer-specific target-
ing in the visual system and boundary formation in wing
imaginal discs (Shishido et al., 1998; Shinza-Kameda et al.,
2006; Milan et al., 2001). Normally, Caps is expressed in a
subset of CNS neurons including aCC, RP2, RP5 and U
motorneurons (Shishido et al., 1998). When Caps is over-
expressed in all neurons, the axons of muscle 12 motorneurons
(MNs) become misrouted. Similar results are obtained when
CapsEd lacking the intracellular domain is misexpressed in
neurons. However, when CapsId lacking the extracellular
domain is misexpressed, no defects can be observed in
pathfinding of muscle 12 MNs. These results clearly indicate
that a neural expression of CapsEd is sufficient to misroute
muscle 12 MNs (Taniguchi et al., 2000). During boundary
formation of the wing discs, cells incorrectly specified for their
position undergo apoptosis because they fail to express Caps
(Milan et al., 2002). Again, exclusive expression of CapsEd is
sufficient to prevent apoptosis of misspecified cells. During
these developmental events, Caps is thought to function as a cell
adhesion molecule providing specific affinity between different
cells and thus, may require only its membrane-anchored
extracellular domain. In contrast, muscularly expressed Caps
requires extracellular and intracellular domain to establish
aberrant synapses of muscle 12 MNs (Taniguchi et al., 2000).
Similarly, only embryos misexpressing complete Caps reveal
interruptions in dorsal and lateral trunks. These results suggest
that Caps requires its intracellular domain both for its function
during the establishment of motorneuron synapses and during
tracheal morphogenesis. This hypothesis was further strength-
ened by investigations using Caps and Trn hybrid proteins in
ectopic expression assays. Misexpression of TrnEdCapsId in
mesodermal cells results in discontinuous tracheal branches.
Moreover, misexpression in trn mutants aggravates the tracheal
defects. These observations suggest that the TrnEdCapsId hybrid
protein functions similar to Caps even though it contains only
the intracellular domain of Caps. Thus, it is the intracellular
domain that determines specificity of Caps function during
tracheal morphogenesis.
Previously, it was postulated that Caps might interact with
receptors on specific motorneurons via its extracellular domain
and transmit the signal into muscles via its intracellular domain
(Taniguchi et al., 2000). Likewise, Caps may function as a
signal transmitter between the tracheal cells and the bridge-
cells. Interestingly, proteins containing LRRs are predicted to
undergo conformational changes upon binding the ligand or
other proteins. These changes do not involve the usual
movement of separate domains relative to each other, but rather
an elastic alteration of the entire structure (Kobe and
Deisenhofer, 1995b). Such conformational changes may
subsequently induce Caps to interact with other intracellular
proteins involved in signaling pathways or regulation of
cytoskeletal structures. It appears that depending on the cell
type, Caps may act as a cell adhesion molecule or as a receptor
that relays signals from the outside to the inside of cells.
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and Anopheles gambiae reveals evolutionary conservation of
three putative motifs within the intracellular domain: a putative
tyrosine phosphorylation site, a predicted PDZ binding motif
and a conserved RHR motif. Site-directed mutagenesis of these
putative functional motifs and in vivo analysis shows that only
the RHR motif is essential for Caps function during tracheal
formation. This RHR motif is not yet recognized as a functional
motif by protein data bases (Gasteiger et al., 2003). Therefore,
no information regarding other proteins containing such a motif
or prediction about its putative function is known. Located
immediately after the transmembrane domain, the RHR motif
may contribute to conformational changes, which enable Caps
to transmit extracellular signals to small membrane-associated
proteins that bind components of signaling pathways or
cytoskeleton.
Caps and Trn act dissimilarly during tracheal development
During the Drosophila wing development, Caps and Trn
share redundant function and contribute evenly to the formation
of affinity boundary between the dorsal and ventral compart-
ments (Milan et al., 2001). This result is rather expected as only
the extracellular domain of Caps or Trn is required during the
establishment of boundary in wing discs and the extracellular
domains of Caps and Trn are 65% identical. Similarly, Trn
requires only its extracellular domain to mediate its function
during the establishment of tracheal network. Our results
demonstrate that the extracellular domain of either Trn or Caps
can rescue the trn tracheal phenotype. Thus, the extracellular
domains of both Caps and Trn provide the mesodermal cellsFig. 7. Model of Caps and Trn function during tracheal system development. (A) Sc
expression of Caps (blue) in the bridge-cells interconnects juxtaposing dorsal trunk
tracheal cells and facilitate tracheal branches towards their proper targets. As a result, a
bridge-cells, guidance function cannot be mediated properly and dorsal trunk cells f
trunk (green) is generated. (c) Ectopic Caps: when mesodermal cells (blue) besides
ectopic Caps and become detached and/or extend in abnormal directions. Thus, an int
tracheal formation. (a) WT: wild-type expression of Trn (orange) in mesodermal cell
the surrounding mesodermal cells as a matrix to determine their positions and migra
interact with cell surface molecules on tracheal cells and thereby mediate a normal out
the matrix function cannot be mediated properly and tracheal cells fail to find their t
tracheal branches (green) are generated. (c) Ectopic Trn: overexpression of Trn in me
type embryos. As a matrix molecule, ectopic Trn may allow the outgrowing tracheal c
targets. Note: The diagram is an oversimplification since only about 20% of the dorwith a substrate that mediates a normal tracheal branch
progression in trn mutants.
On the other hand, Trn and Caps are expressed in divergent
patterns and contribute differently to the formation of continuous
tracheal branches. Whereas caps is expressed selectively in the
bridge-cells, trn is detected in broad subsets of mesodermal cells
excluding the bridge-cells. Furthermore, ectopic expression of
Caps in mesodermal cells disrupts formation of normal tracheal
interconnections while ectopic expression of Trn in mesodermal
cells does not affect tracheal development. Rather, it rescues the
tracheal defects of trn mutant embryos. Finally, although Caps
requires both its extracellular and intracellular domain for proper
function during the formation of tracheal branches, Trn needs
only its extracellular domain.
Based on these observations, we propose the followingmodel
for Caps and Trn functions during tracheal development: Caps is
important for the bridge-cell, which provides instructive cues for
the extending dorsal trunk cells, while Trn contributes to
permissive matrix function of mesodermal cells for normal
tracheal branch outgrowth (Fig. 7). Localized at the surface of
bridge-cells, Capsmay bind to cell surface molecules on tracheal
cells and allow the tracheal cells to extend along the bridge-cells
so that they can find the correct targets. In the absence of caps, the
bridge-cells cannot mediate their local guidance as effectively
and consequently, the dorsal trunk cells fail to interconnect to
their targets. On the other hand, when caps is expressed in
additional mesodermal cells besides the bridge-cells, then the
nearby tracheal cells can also adhere to these mesodermal cells
through Caps and extend in unspecified directions. Thus,
disconnected tracheal branches are formed (Fig. 7A). Previous
studies indicate that specific interactions between cell surfacehematic diagram of Caps function during tracheal formation. (a) WT: wild-type
cells (red). Caps may mediate direct interaction between the bridge-cells and
continuous dorsal trunk is formed. (b) Lack of Caps: when Caps is lacking in the
ail to find their tracheal targets efficiently. Consequently, a discontinuous dorsal
the bridge-cells misexpress caps, the outgrowing dorsal trunk cells may bind
errupted dorsal trunk is formed. (B) A schematic diagram of Trn function during
s located between dorsal trunk and lateral trunk cells. The tracheal cells may use
te towards their targets. Trn expressed on the surface of mesodermal cells may
growth of tracheal cells. (b) Lack of Trn: when trn is lacking in mesodermal cells,
argets efficiently within a specified period of time. Consequently, discontinuous
sodermal cells (orange) mimics closely the endogenous Trn expression in wild-
ells to navigate normally through mesodermal cells and connect properly to their
sal trunk interconnections are affected in caps and trn mutant embryos.
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cells are crucial formigration of tracheal cells (Franch-Marro and
Casanova, 2000). The mesodermal cells may serve as a matrix
enabling (and facilitating) the tracheal cells to recognize the
correct path and to migrate efficiently. These cell-to-cell
interactions might involve transmembrane proteins such as Trn.
Localized at the surface of mesodermal cells, Trn may interact
directly with other molecules on the tracheal cells and thereby
support the tracheal cells to extend across the mesodermal sheet.
When trn is absent, the navigation of outgrowing tracheal cells is
partially hampered and they cannot migrate along their paths as
efficiently. Consequently, they fail to connect to their targets.
Overexpression of Trn in mesodermal cells mimics the wild-type
expression of Trn and does not affect the progression of tracheal
cells (Fig. 7B).
Our results suggest that migrating tracheal branches require
an adhesive substrate provided by the broad expression of Trn in
the immediate proximity. The major airway, the dorsal trunk,
relies additionally on instructive guidance by the extending
bridge-cells expressing Caps, which may bind to surface
molecule(s) on the progressing tracheal cells. The intracellular
domain of Caps might induce signaling leading to cytoskeletal
changes that generate a “pulling” force of the bridge-cells on the
migrating tracheal cells. Identification of extracellular binding
partners on tracheal cells and intracellular interaction partners of
Caps may elucidate molecular mechanisms underlying trans-
mission of external cues in the bridge-cells that induce
intracellular events leading to cellular guidance.
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